Biomarkers Market Growing at 13.58% CAGR to 2020

Aug 21, 2015, 14:20 ET from ReportsnReports

PUNE, India, August 21, 2015 /PRNewswire/ --

Global Biomarkers Industry 2015 Market Research Report and Biomarkers Market by Product, Type, Application and by Disease Indication with Global Forecasts to 2020 are the new biotechnology market research reports added to online library of

Complete global biomarkers market 2015 research report spread across 171 pages, profiling and analyzing 11 companies and supported with 190 tables and figures is now available at .

This 2015 biomarkers market research profiles and analyzes companies like Qiagen, Perkinelmer, Merck & Co, Bio-Rad Laboratories, Enzo Biochem, Ekf Diagnostics Holdings, Meso Scale Diagnostics, Singulex, Biosims Technologies, Cisbio Bioassays and Signosis. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The biomarkers market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures of the biomarkers market are analyzed in this research. It states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading industry players of biomarkers market, as listed above, providing their information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The biomarkers market development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 190 tables and figures to support the biomarkers market analysis, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Order a copy of Global Biomarkers Industry 2015 Market Research Report at .

The second research titled Biomarkers Market by Product (Consumables, Services), Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine) & by Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020 forecasts a 13.58% CAGR for the industry to reach $45.55 Billion by 2020. Increasing healthcare and R&D expenditure are the key growth drivers in this market. However, poorly suited regulatory & reimbursement systems, high cost of tests and sample collection & storage may hinder the growth of this market. Diagnostics development, by application, accounted for the largest share of the global biomarkers market in 2015. On the other hand, personalized medicine is expected to grow at the highest rate. Consumables, by product, accounted for the largest share and are expected to show the highest growth.

In this report, the biomarkers market is segmented on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, software. The type segments included in this report are safety biomarkers, efficacy biomarkers, and validation biomarkers. The applications segments included in this report are diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and other applications. The disease indications segments included in this report are cancer, cardiovascular disorders, neurological disorders, immunological disorders and other diseases. The geographic segments included in this report are North America, Europe, Asia and the Rest of the World (RoW).

The growth of biomarkers market is mainly driven by increasing healthcare expenditure, increase in R&D spending, increasing utility of biomarkers for diagnostics, increasing number of CROs, the low cost of clinical trials in developing countries, and new initiatives for biomarker research. The high growth potential in emerging markets and the increasing adoption of personalized medicine and companion diagnostics provides new growth opportunities to players in the biomarkers market. The report provides qualitative insights on key market shares, growth rates, and market drivers for important sub segments. It maps the market sizes and growth rates of each segment and identifies segments poised to witness rapid growth. The report includes company profiles and a competitive landscape of the biomarkers market. The company profiles include the financial performances, product portfolios, and developments of each company, whereas, the competitive landscape covers the growth strategies adopted by industry players over the last three years. The report also includes analyses of industry developments such as acquisitions, agreements, collaborations & partnerships; new product launches; and other developments.

Companies like Bio-Rad Laboratories, Inc., EKF Diagnostics Holdings, Inc., ENZO Biochem, Inc., Merck & Co, Inc., Perkinelmer, Inc., Qiagen N.V., Biosims Technologies, Cisbio Bioassays, Meso Scale Diagnostics, LLC. and Signosis, Inc. are profiled in this biomarkers market research to 2020 available at .

For the biotechnology industry and specifically the biomarkers market segment, has multiple newly published and relevant research titles:

Global Biomarker Partnering 2010-2015: Deal trends, players, financials and forecasts: This research provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the world's leading healthcare companies along with specific information on trends in biomarker partnering deals, biomarker partnering agreement structure, biomarker partnering contract documents, top biomarker deals by value and most active biomarker dealmakers. This report contains over 650 links to online copies of actual biomarker deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. The report presents average financial deal terms values for biomarker deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyze and benchmark the value of current deals. Each deal title links via weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. Read more at .

Explore more reports on the biotechnology industry at .

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Connect With Us on:



Twitter: https: //

G+ / Google Plus:


RSS/Feeds: http: //


Ritesh Tiwari

UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013

Maharashtra, India.

+ 1 888 391 5441


SOURCE ReportsnReports